Boom-IBD Clinical Trial

  • End date
    Dec 10, 2026
  • participants needed
  • sponsor
    Boomerang Medical
Updated on 10 April 2023


Early feasibility study of neuromodulation in patients with IBD.


The study will evaluate responses of patients with IBD treated with neuromodulation at various intervals.

Condition IBD
Treatment neuromodulation
Clinical Study IdentifierNCT05414955
SponsorBoomerang Medical
Last Modified on10 April 2023


Yes No Not Sure

Inclusion Criteria

Male or female
to 75 years of age
Disease duration of ≥ 6 months
Ability and willingness to consent to participate by signing the informed consent form
Ability to comply with the protocol and willingness to comply with all follow-up requirements
General Exclusion Criteria (The subject must not meet ANY of the following
Any significant medical condition that is likely to interfere with study procedures, device operation, or likely to confound the results of the study
Any psychiatric or personality disorder at the discretion of the study investigator
History or current evidence of alcohol or drug abuse or dependence, recreational use of illicit drug or prescription medications
Any active bacterial infection with a risk of bacteremia or sepsis (e.g. presence of abscess)
Active clostridium difficile infection of the colon
Active cytomegalovirus (CMV) infection of the colon
Evidence of colonic perforation
Fulminant colitis requiring emergency surgery
Microscopic, ischemic or infectious colitis
Unresected neoplasia of the colon
History of proctocolectomy
Colonic stricture unable to pass a colonoscope
Active or latent tuberculosis
History of cancer including melanoma (except for localized skin cancers) within 2 years
Participation in another clinical trial within the past 30 days of device implant
Investigational drug for the treatment of inflammatory bowel disease within 6 months of device implant
Inability to operate the patient programmer
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note